Cargando…
The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study
BACKGROUND: Continuous renal replacement therapy (CRRT) has been considered as an adjuvant therapy for sepsis. However, the novel biomarker to evaluate the benefits of CRRT is limited. The aim of this study was to explore the novel biomarkers involved in the impact of CRRT in pediatric sepsis. METHO...
Autores principales: | Cui, Yun, Feng, Shuyun, Miao, Huijie, Liu, Tiantian, Shi, Jingyi, Dou, Jiaying, Wang, Chunxia, Zhang, Yucai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847018/ https://www.ncbi.nlm.nih.gov/pubmed/36650427 http://dx.doi.org/10.1186/s12014-023-09392-2 |
Ejemplares similares
-
Continuous renal replacement therapy attenuates polymorphonuclear myeloid-derived suppressor cell expansion in pediatric severe sepsis
por: Feng, Shuyun, et al.
Publicado: (2022) -
Continuous Renal Replacement Therapy in Pediatric Severe Sepsis: A Propensity Score-Matched Prospective Multicenter Cohort Study in the PICU
por: Miao, Huijie, et al.
Publicado: (2019) -
Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU
por: Wang, Chunxia, et al.
Publicado: (2020) -
Commentary: Plasma Metabolic Profiling of Pediatric Sepsis in a Chinese Cohort
por: Liu, Tiantian, et al.
Publicado: (2021) -
Serum proteome‐wide identified ATP citrate lyase as a novel informative diagnostic and prognostic biomarker in pediatric sepsis: A pilot study
por: Wang, Chunxia, et al.
Publicado: (2020)